Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06593366 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fecal Microbiota Transplant for Anorexia Nervosa

Study acronym: FMT-AN
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: McMaster University to Hamilton Health Sciences Corporation
    • Primary and study completion dates: Jun 2026 to Jun 1, 2027
    • Start date: Jan 1, 2025 to Jun 1, 2026
    • Collaborators expanded, about 7 words
    v3
  2. Start date: Sep 30, 2024 to Jan 1, 2025v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this pilot randomized-controlled trial is to determine whether Fecal Microbiota Transplant (FMT) treatment demonstrates feasibility, acceptability, and prelinary effectiveness among patients with anorexia nervosa (AN). Specifically, the investigators aim to compare changes in weight, gut microbiome, urine, blood biomarkers and mood symptoms between participants receiving the FMT intervention and placebo.
Trial Details
NCT Number NCT06593366
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: McMaster University, Hamilton Academic Health Sciences Organization
Conditions
(from sponsor)		 Anorexia Nervosa Restricting Type, Anorexia Nervosa, Anorexia in Adolescence, Anorexia in Children, Anorexia
Related terms Anorexia, Anorexia Nervosa
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov